Febusez 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and complications associated with elevated uric acid, such as joint inflammation and kidney stones. Febusez 40 is typically prescribed for patients who have not responded well to other urate-lowering therapies or who have contraindications to alternative treatments like allopurinol. The tablet is taken orally, usually once daily, with or without food, and dosage adjustments may be necessary based on renal function and patient response. Common side effects include nausea, joint pain, rash, and liver enzyme abnormalities, though serious adverse effects are rare when used as directed. Patients are advised to maintain adequate hydration and avoid alcohol to enhance treatment efficacy and minimize side effects. Febusez 40 should be used under medical supervision, especially in individuals with cardiovascular conditions or liver impairment. Regular monitoring of serum uric acid levels and liver function tests is recommended to ensure safe and effective therapy.